Try our Advanced Search for more refined results
Clients
- AbbVie Inc.
- Agilent Technologies Inc.
- Allergan PLC
- Amazon.com Inc.
- Amgen Inc.
- Amicus
- Anacor Pharmaceuticals Inc.
- Array BioPharma Inc.
- Axalta Coating Systems Ltd.
- Azurity Pharmaceuticals Inc.
- Bayer AG
- Boehringer Ingelheim Corp.
- Bristol-Myers Squibb Co.
- Cognizant Technology Solutions Corp.
- Edwards Lifesciences Corp.
- Exelixis Inc.
- First Solar Inc.
- Forest Laboratories Inc.
- Galderma SA
- Gedeon Richter PLC
- Gilead Sciences Inc.
- Global Blood Therapeutics Inc.
- Grunenthal Group
- H. Lundbeck A S
- Harmony Biosciences Holdings Inc.
- Horizon Therapeutics PLC
- Inari Agriculture Inc.
- Indivior PLC
- Ionis Pharmaceuticals
- Keryx Biopharmaceuticals Inc.
- Les Laboratoires Servier
- Merck & Co. Inc.
- Mitsubishi Tanabe Pharma Corp.
- Nestle SA
- Neurocrine Biosciences Inc.
- News Corp.
- Pfizer Inc.
- Pharmacyclics, Inc.
- Pindrop Security Inc.
- Puma Biotechnology Inc.
- Purdue Pharma LP
- Research Corporation Technologies Inc.
- Sarepta Therapeutics Inc.
- Seoul Semiconductor Co. Ltd.
- Seoul Viosys Co. Ltd.
- Takeda Pharmaceutical Co. Ltd.
- The Scripps Research Institute
- UCB SA
- Vertex Pharmaceuticals Inc.
- Waste Management Inc.
- Zogenix Inc.
- iRhythm Technologies Inc.
Megan E. Dellinger (Wilmington, DE)
Firm: Morris Nichols
Total (330)
-
April 03, 2026
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Ridhisidhi PLLC, Delaware
Patent - Abbreviated New Drug Application(ANDA) | Delaware
-
March 26, 2026
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Ipca Laboratories Ltd., Delaware
Patent - Abbreviated New Drug Application(ANDA) | Delaware
-
March 24, 2026
Onyx Therapeutics, Inc. v. Hetero USA Inc. et al, Delaware
Patent - Abbreviated New Drug Application(ANDA) | Delaware